TERAZOSIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Terazosin Hydrochloride patents expire, and when can generic versions of Terazosin Hydrochloride launch?
Terazosin Hydrochloride is a drug marketed by Apnar Pharma Lp, Bionpharma, Heritage Pharma Avet, Hikma, Jubilant Cadista, Norvium Bioscience, Ranbaxy Labs Ltd, Chartwell Rx, Ivax Sub Teva Pharms, Sandoz, and Teva. and is included in twelve NDAs.
The generic ingredient in TERAZOSIN HYDROCHLORIDE is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Terazosin Hydrochloride
A generic version of TERAZOSIN HYDROCHLORIDE was approved as terazosin hydrochloride by APNAR PHARMA LP on March 30th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TERAZOSIN HYDROCHLORIDE?
- What are the global sales for TERAZOSIN HYDROCHLORIDE?
- What is Average Wholesale Price for TERAZOSIN HYDROCHLORIDE?
Summary for TERAZOSIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 21 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Clinical Trials: | 24 |
| Patent Applications: | 1,548 |
| DailyMed Link: | TERAZOSIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TERAZOSIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| CNR Pisa | Phase 4 |
| I.R.C.C.S. Fondazione Santa Lucia | Phase 4 |
| Università Foro Italico Roma | Phase 4 |
Pharmacology for TERAZOSIN HYDROCHLORIDE
| Drug Class | alpha-Adrenergic Blocker |
| Mechanism of Action | Adrenergic alpha-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for TERAZOSIN HYDROCHLORIDE
US Patents and Regulatory Information for TERAZOSIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | TERAZOSIN HYDROCHLORIDE | terazosin hydrochloride | TABLET;ORAL | 074315-001 | Dec 31, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ranbaxy Labs Ltd | TERAZOSIN HYDROCHLORIDE | terazosin hydrochloride | CAPSULE;ORAL | 076021-004 | Aug 22, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | TERAZOSIN HYDROCHLORIDE | terazosin hydrochloride | TABLET;ORAL | 074446-001 | May 18, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | TERAZOSIN HYDROCHLORIDE | terazosin hydrochloride | CAPSULE;ORAL | 075384-004 | Dec 1, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
